Viewing Study NCT00941759


Ignite Creation Date: 2025-12-24 @ 2:48 PM
Ignite Modification Date: 2025-12-27 @ 12:06 PM
Study NCT ID: NCT00941759
Status: COMPLETED
Last Update Posted: 2025-07-16
First Post: 2009-07-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Analysis of Surgery in Patients Presenting With Stage IV Breast Cancer
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:

Study Overview

Official Title: A Prospective Analysis of Surgery in Patients Presenting With Stage IV Breast Cancer
Status: COMPLETED
Status Verified Date: 2025-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of this study is to study patients presenting with stage IV breast cancer. Stage IV means that the breast cancer has spread to another part of the body outside the breast. This study is important because in different parts of the country some patients are being offered surgical treatment for the breast tumor and some are not. The doctors do not know if surgery for the breast tumor is helpful in patients with stage IV breast cancer. The doctors will collect information about the patient and their treatment to learn more about how patients and doctors make treatment decisions. The doctor will also collect blood samples and tissue samples for laboratory studies to learn more about tumors that have spread to other parts of the body.
Detailed Description: None

Study Oversight

Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?: